Gastrointestinal Oncology

The Gastrointestinal Oncology Unit specializes in the diagnosis and medical treatment of tumors affecting the stomach and esophagus, small intestine, colon-rectum and anus, pancreas, biliary tract, appendix (including the clinical syndrome pseudomyxoma peritonei), as well as abdominal, thoracic, and cutaneous neuroendocrine tumors (including Merkel cell carcinoma). 

Given their complexity, gastrointestinal tract neoplasms in our institution are managed through a diagnostic and therapeutic approach shared among multiple specialists from the very first patient visit. In collaboration with surgeons, gastroenterology endoscopists, radiologists, nutritionists, radiation therapists, palliative care physicians, and pathologists, a multidisciplinary treatment plan is developed. This multidisciplinary treatment plan ensures optimal timing and coordination of interventions and diagnostic procedures. Additionally, our Unit emphasizes the importance of patient comprehension of the disease and adjusts care, where feasible, to address individual needs, with careful consideration of communication and psychological factors. We are also engaged in research focused on minimizing potential disparities in access to care. 

Each patient receives a cutting-edge care plan, and clinical research often allows us to offer innovative treatments such as those targeting genetic characteristics, immunotherapy, or novel treatment mechanisms. 

Our team is deeply committed to designing and conducting academic clinical studies to improve practice and therapeutic strategies for gastrointestinal tumors. Some of our staff members hold significant positions in professional associations and scientific networks, such as the GONO Foundation, known for developing treatments recommended in international guidelines.  

Our research has contributed to defining current treatment standards for gastrointestinal cancers, including colorectal and gastroesophageal carcinomas. 

Finally, we actively participate in drafting national and international guidelines for the treatment of gastrointestinal tumors, serving as a global reference for clinical and scientific activities. Our team meets regularly to ensure synergy among different professionals (physicians, research nurses, study coordinators), maintain continuous scientific updates, and uphold consistency in therapeutic strategy formulation.